{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:22:06Z","timestamp":1778865726706,"version":"3.51.4"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ30298"],"award-info":[{"award-number":["2022JJ30298"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ40183"],"award-info":[{"award-number":["2022JJ40183"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFF0700304"],"award-info":[{"award-number":["2021YFF0700304"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32172844"],"award-info":[{"award-number":["32172844"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32202790"],"award-info":[{"award-number":["32202790"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijbiomac.2025.147967","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T17:19:12Z","timestamp":1758993552000},"page":"147967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Nanoparticle-based antigen favors high level of humoral immune responses and increases antigenicity of highly glycosylated protein"],"prefix":"10.1016","volume":"330","author":[{"given":"Yawen","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfeng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beilei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dantong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Khayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147967_bb0005","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1002\/jcp.28120","article-title":"Nanovaccine: a novel approach in immunization","volume":"234","author":"Gheibi Hayat","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0010","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12951-022-01477-8","article-title":"Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists","volume":"20","author":"Joudeh","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-319-39196-0_5","article-title":"Assembly, engineering and applications of virus-based protein nanoparticles","volume":"940","author":"Mateu","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.33073\/pjm-2015-001","article-title":"Virus like particles as immunogens and universal nanocarriers","volume":"64","author":"Naskalska","year":"2015","journal-title":"Pol. J. Microbiol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147967_bb0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/14760584.2020.1738227","article-title":"Genetic engineering strategies for construction of multivalent chimeric VLPs vaccines","volume":"19","author":"Lei","year":"2020","journal-title":"Expert Rev. Vaccines"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147967_bb0035","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/nar\/11.9.2745","article-title":"Expression of hepatitis B virus surface antigen in yeast","volume":"11","author":"Hitzeman","year":"1983","journal-title":"Nucleic Acids Res."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.147967_bb0040","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1073\/pnas.81.24.7708","article-title":"Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin","volume":"81","author":"Michel","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147967_bb0045","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/infdis\/171.6.1576","article-title":"Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine","volume":"171","author":"Gordon","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0050","doi-asserted-by":"crossref","first-page":"46621","DOI":"10.1038\/srep46621","article-title":"Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine","volume":"7","author":"Collins","year":"2017","journal-title":"Sci. Rep."},{"issue":"7456","key":"10.1016\/j.ijbiomac.2025.147967_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147967_bb0060","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00705-016-2816-9","article-title":"Generation of E. coli-derived virus-like particles of porcine circovirus type 2 and their use in an indirect IgG enzyme-linked immunosorbent assay","volume":"161","author":"Zhang","year":"2016","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vaccine.2018.11.021","article-title":"Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen","volume":"37","author":"Diamos","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.antiviral.2017.01.003","article-title":"Porcine parvovirus capsid protein expressed in Escherichia coli self-assembles into virus-like particles with high immunogenicity in mice and guinea pigs","volume":"139","author":"Ji","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.633706","article-title":"The high immunity induced by the virus-like particles of foot-and-mouth disease virus serotype O","volume":"8","author":"Xiao","year":"2021","journal-title":"Front. Vet. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/v13030388","article-title":"Adenovirus core proteins: structure and function","volume":"13","author":"Kulanayake","year":"2021","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147967_bb0085","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/infdis\/jiz555","article-title":"Human papillomavirus vaccine effectiveness against HPV infection: evaluation of one, two, and three doses","volume":"221","author":"Markowitz","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147967_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/v14092005","article-title":"Porcine circovirus type 2 vaccines: commercial application and research advances","volume":"14","author":"Guo","year":"2022","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.147967_bb0095","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3390\/microorganisms8111745","article-title":"New technologies for influenza vaccines","volume":"8","author":"Rockman","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0100","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.18749.1","article-title":"The long road to protect infants against severe RSV lower respiratory tract illness","volume":"8","author":"Jares Baglivo","year":"2019","journal-title":"F1000Res"},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.147967_bb0105","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.147967_bb0110","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk Virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/14760584.2020.1738225","article-title":"The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms","volume":"19","author":"O\u2019Donnell","year":"2020","journal-title":"Expert Rev. Vaccines"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147967_bb0120","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/biot.201400438","article-title":"The baculovirus expression vector system: a commercial manufacturing platform for viral vaccines and gene therapy vectors","volume":"10","author":"Felberbaum","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-animal-031412-103720","article-title":"Porcine circovirus type 2 (PCV2): pathogenesis and interaction with the immune system","volume":"1","author":"Meng","year":"2013","journal-title":"Annu. Rev. Anim. Biosci."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2025.147967_bb0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1865-1682.2011.01291.x","article-title":"Emerging and re-emerging swine viruses","volume":"59","author":"Meng","year":"2012","journal-title":"Transbound. Emerg. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13568-019-0940-0","article-title":"Self-assembly into virus-like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection","volume":"10","author":"Wang","year":"2020","journal-title":"AMB Express"},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.147967_bb0140","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1007\/s00253-018-9278-9","article-title":"Mutation in the VP2 gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O","volume":"102","author":"Ganji","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2020.01.007","article-title":"Shaping humoral immunity to vaccines through antigen-displaying nanoparticles","volume":"65","author":"Irvine","year":"2020","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147967_bb0150","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cell.2019.02.008","article-title":"Self-assembling nanoparticles usher in a new era of vaccine design","volume":"176","author":"Rappuoli","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147967_bb0155","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.cell.2019.01.046","article-title":"Induction of potent neutralizing antibody responses by a designed protein nanoparticle vaccine for respiratory syncytial virus","volume":"176","author":"Marcandalli","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41541-021-00330-7","article-title":"Protein-based antigen presentation platforms for nanoparticle vaccines","volume":"6","author":"Nguyen","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0165","doi-asserted-by":"crossref","first-page":"19234","DOI":"10.1038\/srep19234","article-title":"Plug-and-display: decoration of virus-like particles via isopeptide bonds for modular immunization","volume":"6","author":"Brune","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-016-0181-1","article-title":"Bacterial superglue enables easy development of efficient virus-like particle based vaccines","volume":"14","author":"Thrane","year":"2016","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147967_bb0175","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/acsnano.0c08379","article-title":"Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates","volume":"15","author":"Kang","year":"2021","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.147967_bb0180","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147967_bb0185","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1021\/acsnano.2c08840","article-title":"Engineered norovirus-derived nanoparticles as a plug-and-play cancer vaccine platform","volume":"17","author":"Zheng","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nano.2018.11.009","article-title":"Ferritin nanoparticle-based SpyTag\/SpyCatcher-enabled click vaccine for tumor immunotherapy","volume":"16","author":"Wang","year":"2019","journal-title":"Nanomedicine"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.147967_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113449","article-title":"Nimotuzumab site-specifically labeled with (89)Zr and (225)Ac using SpyTag\/SpyCatcher for PET imaging and alpha particle radioimmunotherapy of epidermal growth factor receptor positive cancers","volume":"12","author":"Solomon","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0200","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41467-020-20251-8","article-title":"Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity","volume":"12","author":"Fougeroux","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0205","article-title":"A vaccine displaying a trimeric influenza-A HA stem protein on capsid-like particles elicits potent and long-lasting protection in mice","volume":"8","author":"Thrane","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"48","key":"10.1016\/j.ijbiomac.2025.147967_bb0210","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ac842c","article-title":"Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein","volume":"33","author":"Ximba","year":"2022","journal-title":"Nanotechnology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0215","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01552-21","article-title":"The glycan hole area of HIV-1 envelope trimers contributes prominently to the induction of autologous neutralization","volume":"96","author":"Schorcht","year":"2022","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.147967_bb0220","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"1863","author":"Watanabe","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0225","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41467-020-16567-0","article-title":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation","volume":"11","author":"Watanabe","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.147967_bb0230","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1128\/JVI.01994-10","article-title":"Processing and localization of the african swine fever virus CD2v transmembrane protein","volume":"85","author":"Goatley","year":"2011","journal-title":"J. Virol."},{"issue":"31","key":"10.1016\/j.ijbiomac.2025.147967_bb0235","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1073\/pnas.1006498107","article-title":"Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens","volume":"107","author":"Doores","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"28","key":"10.1016\/j.ijbiomac.2025.147967_bb0240","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1073\/pnas.1803990115","article-title":"Structure of the Lassa virus glycan shield provides a model for immunological resistance","volume":"115","author":"Watanabe","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/v8030055","article-title":"Identification and comparison of receptor binding characteristics of the spike protein of two porcine epidemic diarrhea virus strains","volume":"8","author":"Deng","year":"2016","journal-title":"Viruses"},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.147967_bb0250","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00923-19","article-title":"The 3.1-Angstrom cryo-electron microscopy structure of the porcine epidemic diarrhea virus spike protein in the prefusion conformation","volume":"93","author":"Wrapp","year":"2019","journal-title":"J. Virol."},{"issue":"6501","key":"10.1016\/j.ijbiomac.2025.147967_bb0255","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.147967_bb0260","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.celrep.2016.02.058","article-title":"Composition and antigenic effects of individual glycan sites of a trimeric HIV-1 envelope glycoprotein","volume":"14","author":"Behrens","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-022-03767-1","article-title":"Glycan shield of the ebolavirus envelope glycoprotein GP","volume":"5","author":"Peng","year":"2022","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0270","article-title":"In situ structure and dynamics of an alphacoronavirus spike protein by cryo-ET and cryo-EM","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.147967_bb0275","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41557-021-00758-3","article-title":"A glycan gate controls opening of the SARS-CoV-2 spike protein","volume":"13","author":"Sztain","year":"2021","journal-title":"Nat. Chem."},{"issue":"6530","key":"10.1016\/j.ijbiomac.2025.147967_bb0280","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abf6840","article-title":"Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice","volume":"371","author":"Cohen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0285","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40813-020-00159-x","article-title":"Major swine viral diseases: an Asian perspective after the African swine fever introduction","volume":"6","author":"Kedkovid","year":"2020","journal-title":"Porcine Health Manag."},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0290","doi-asserted-by":"crossref","first-page":"40643","DOI":"10.34172\/ipp.2025.40643","article-title":"Cloning and expression of UbiA human gene using innovative methodologies for recombinant protein production in PUAST vector","volume":"11","author":"Dragh","year":"2025","journal-title":"Immunopathol. Persa"},{"issue":"Pt 4","key":"10.1016\/j.ijbiomac.2025.147967_bb0295","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1107\/S2059798318005119","article-title":"Structural analysis of glycoproteins: building N-linked glycans with coot","volume":"74","author":"Emsley","year":"2018","journal-title":"Acta Crystallogr. D Struct. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0300","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0305","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-018-1052-1","article-title":"Screening and identification of B-cell epitopes within envelope protein of tembusu virus","volume":"15","author":"Zhao","year":"2018","journal-title":"Virol. J."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147967_bb0310","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","article-title":"Engineering a rugged nanoscaffold to enhance plug-and-display vaccination","volume":"12","author":"Bruun","year":"2018","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147967_bb0315","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.xphs.2018.11.029","article-title":"The mechanistic impact of N-glycosylation on stability, pharmacokinetics, and immunogenicity of therapeutic proteins","volume":"108","author":"Zhou","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0320","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tibs.2006.01.003","article-title":"N-linked oligosaccharides as outfitters for glycoprotein folding, form and function","volume":"31","author":"Mitra","year":"2006","journal-title":"Trends Biochem. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147967_bb0325","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tim.2007.03.003","article-title":"Virus glycosylation: role in virulence and immune interactions","volume":"15","author":"Vigerust","year":"2007","journal-title":"Trends Microbiol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147967_bb0330","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.celrep.2019.04.082","article-title":"The chimpanzee SIV envelope trimer: structure and deployment as an HIV vaccine template","volume":"27","author":"Andrabi","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108933","article-title":"Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike","volume":"35","author":"Derking","year":"2021","journal-title":"Cell Rep."},{"issue":"Pt 4","key":"10.1016\/j.ijbiomac.2025.147967_bb0340","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1099\/jgv.0.000024","article-title":"African swine fever virus CD2v and C-type lectin gene loci mediate serological specificity","volume":"96","author":"Malogolovkin","year":"2015","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147967_bb0345","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11262-021-01879-0","article-title":"A systematic review of genotypes and serogroups of African swine fever virus","volume":"58","author":"Qu","year":"2022","journal-title":"Virus Genes"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147967_bb0350","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3201\/eid2102.140649","article-title":"Comparative analysis of African swine fever virus genotypes and serogroups","volume":"21","author":"Malogolovkin","year":"2015","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0014-5793(96)00384-5","article-title":"CMP-N-acetylneuraminic acid hydroxylase: the first cytosolic Rieske iron-sulphur protein to be described in Eukarya","volume":"385","author":"Schlenzka","year":"1996","journal-title":"FEBS Lett."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.147967_bb0360","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1128\/JVI.00628-15","article-title":"Comparative analysis of the glycosylation profiles of membrane-anchored HIV-1 envelope glycoprotein trimers and soluble gp140","volume":"89","author":"Go","year":"2015","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.147967_bb0365","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/intimm\/dxad030","article-title":"The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells","volume":"35","author":"Tsubata","year":"2023","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0370","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8479","article-title":"Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies","volume":"6","author":"Pritchard","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147967_bb0375","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1073\/pnas.79.2.395","article-title":"Specific cellular stimulation in the primary immune response: a quantized model","volume":"79","author":"Vogelstein","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115992","article-title":"Nanovaccines: an effective therapeutic approach for cancer therapy","volume":"170","author":"Gurunathan","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147967_bb0385","first-page":"20210082","article-title":"Nanotechnology-facilitated vaccine development during the coronavirus disease 2019 (COVID-19) pandemic","volume":"2","author":"Ziqi","year":"2022","journal-title":"Exploration (Beijing)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0390","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12951-022-01710-4","article-title":"A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.147967_bb0395","doi-asserted-by":"crossref","first-page":"12235","DOI":"10.1021\/acsnano.4c00809","article-title":"Combination of S1-N-terminal and S1-C-terminal domain antigens targeting double receptor-binding domains bolsters protective immunity of a nanoparticle vaccine against porcine epidemic diarrhea virus","volume":"18","author":"Yang","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0400","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","article-title":"In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles","volume":"112","author":"Reddy","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0405","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fonc.2018.00404","article-title":"Interactions between nanoparticles and dendritic cells: from the perspective of cancer immunotherapy","volume":"8","author":"Jia","year":"2018","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.147967_bb0410","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0415","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.immunol.15.1.235","article-title":"Neutralizing antiviral B cell responses","volume":"15","author":"Bachmann","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0420","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12041","article-title":"Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles","volume":"7","author":"He","year":"2016","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147967_bb0425","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","article-title":"Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses","volume":"53","author":"Ma","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0430","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41467-020-20654-7","article-title":"A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses","volume":"12","author":"Tan","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0435","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/anie.202009663","article-title":"Overcoming symmetry mismatch in vaccine nanoassembly through spontaneous amidation","volume":"60","author":"Rahikainen","year":"2021","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147967_bb0440","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.tim.2022.02.004","article-title":"Glycans in HIV-1 vaccine design - engaging the shield","volume":"30","author":"Deimel","year":"2022","journal-title":"Trends Microbiol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.147967_bb0445","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.celrep.2015.05.017","article-title":"Structural constraints determine the glycosylation of HIV-1 envelope trimers","volume":"11","author":"Pritchard","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0450","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3389\/fimmu.2018.00910","article-title":"Glycan shielding and modulation of hepatitis C virus neutralizing antibodies","volume":"9","author":"Lavie","year":"2018","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.147967_bb0455","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/v3101909","article-title":"The hepatitis C virus glycan shield and evasion of the humoral immune response","volume":"3","author":"Helle","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0460","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/794143","article-title":"An overview of pathogen recognition receptors for innate immunity in dental pulp","volume":"2015","author":"Jang","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"6179","key":"10.1016\/j.ijbiomac.2025.147967_bb0465","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/334255a0","article-title":"Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells","volume":"334","author":"Stevens","year":"1988","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.147967_bb0470","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147967_bb0475","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0480","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2010.08.012","article-title":"Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems","volume":"147","author":"Mohanan","year":"2010","journal-title":"J. Control. Release"},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.147967_bb0485","doi-asserted-by":"crossref","first-page":"20825","DOI":"10.1021\/acsnano.3c05853","article-title":"Size-dependent in vivo transport of nanoparticles: implications for delivery, targeting, and clearance","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0490","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jconrel.2016.05.033","article-title":"Orchestrating immune responses: how size, shape and rigidity affect the immunogenicity of particulate vaccines","volume":"234","author":"Benne","year":"2016","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147967_bb0495","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41577-023-00970-x","article-title":"Therapeutic induction of antigen-specific immune tolerance","volume":"24","author":"Kenison","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0500","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/acsnano.0c03023","article-title":"Glycan-modified virus-like particles evoke T helper type 1-like immune responses","volume":"15","author":"Alam","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0505","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-4690-10-14","article-title":"A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization","volume":"10","author":"Wang","year":"2013","journal-title":"Retrovirology"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147967_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0515","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tvjl.2014.02.002","article-title":"Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines","volume":"200","author":"Seo","year":"2014","journal-title":"Vet. J."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.147967_bb0520","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1128\/JVI.00737-11","article-title":"The 2.3-angstrom structure of porcine circovirus 2","volume":"85","author":"Khayat","year":"2011","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147967_bb0525","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01836-19","article-title":"Neutralization mechanism of a monoclonal antibody targeting a porcine circovirus type 2 cap protein conformational epitope","volume":"94","author":"Huang","year":"2020","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007562","article-title":"Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope","volume":"15","author":"Mo","year":"2019","journal-title":"PLoS Pathog."},{"issue":"45","key":"10.1016\/j.ijbiomac.2025.147967_bb0535","doi-asserted-by":"crossref","first-page":"11495","DOI":"10.1073\/pnas.1806068115","article-title":"Global trends in infectious diseases of swine","volume":"115","author":"VanderWaal","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0540","doi-asserted-by":"crossref","first-page":"469","DOI":"10.18388\/abp.2016_1275","article-title":"Virus-like particles as drug delivery vectors","volume":"63","author":"Zdanowicz","year":"2016","journal-title":"Acta Biochim. Pol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0545","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bbrc.2009.10.016","article-title":"The \u201cTrojan horse\u201d model-delivery of anti-HBV small interfering RNAs by a recombinant HBV vector","volume":"390","author":"Shlomai","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147967_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2022.152317","article-title":"Nanoparticle-induced immune response: health risk versus treatment opportunity?","volume":"228","author":"Pondman","year":"2023","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147967_bb0555","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1113\/jphysiol.2013.266700","article-title":"In vivo quantification of lymph viscosity and pressure in lymphatic vessels and draining lymph nodes of arthritic joints in mice","volume":"592","author":"Bouta","year":"2014","journal-title":"J. Physiol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147967_bb0560","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147967_bb0565","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4049\/jimmunol.1801677","article-title":"Self-antigens displayed on liposomal nanoparticles above a threshold of epitope density elicit class-switched autoreactive antibodies independent of T cell help","volume":"204","author":"Chen","year":"2020","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147967_bb0570","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.immuni.2023.02.003","article-title":"B cell receptor signaling in germinal centers prolongs survival and primes B cells for selection","volume":"56","author":"Chen","year":"2023","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147967_bb0575","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.immuni.2018.08.012","article-title":"B cells are the dominant antigen-presenting cells that activate naive CD4(+) T cells upon immunization with a virus-derived nanoparticle antigen","volume":"49","author":"Hong","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2025.147967_bb0580","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.1980.tb01039.x","article-title":"The follicular dendritic cell: long term antigen retention during immunity","volume":"53","author":"Mandel","year":"1980","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147967_bb0585","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4049\/jimmunol.172.1.61","article-title":"Sustained IL-12 signaling is required for Th1 development","volume":"172","author":"Athie-Morales","year":"2004","journal-title":"J. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025085241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025085241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:03:42Z","timestamp":1762477422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025085241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":117,"alternative-id":["S0141813025085241"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147967","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle-based antigen favors high level of humoral immune responses and increases antigenicity of highly glycosylated protein","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"147967"}}